IVF INVO Fertility, Inc. logo

IVF INVO Fertility, Inc.

Healthcare
$1.64+3.80%ClosedMarket Cap: $2.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.40

P/S

0.33

EV/EBITDA

-0.74

DCF Value

$-10,511.80

FCF Yield

-340.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

31.4%

Operating Margin

-139.2%

Net Margin

-394.9%

ROE

-446.6%

ROA

-145.6%

ROIC

-88.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$1.8M$-2.6M$
Q2 null$1.9M$-3.8M$
Q1 null$1.6M$-17.4M$
Q4 null$1.7M$-3.6M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$20.00

Target (Median)

$20.00

Target Range

$20.00 - $20.00

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

2.32

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.

Peers